Abstract
Disseminated superficial actinic porokeratosis (DSAP) is typically progressive and lifelong,1-3 but little data are available regarding the impact of DSAP on quality of life (QoL). We sought to identify the overall impairment of QoL in patients with DSAP, assess correlations in QoL impairment, and measure the impact of treatment on QoL.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
